Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | yes | yes: 6 |
Forrest at al. (procyclic) | yes | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 24 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005886 | plasma membrane | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
GO:0031253 | cell projection membrane | 4 | 1 |
GO:0060170 | ciliary membrane | 5 | 1 |
GO:0098588 | bounding membrane of organelle | 4 | 1 |
GO:0098590 | plasma membrane region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I2W4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 74 | 78 | PF00656 | 0.478 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.520 |
CLV_NRD_NRD_1 | 249 | 251 | PF00675 | 0.535 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.401 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.520 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.435 |
DEG_ODPH_VHL_1 | 301 | 314 | PF01847 | 0.509 |
DOC_MAPK_gen_1 | 111 | 122 | PF00069 | 0.503 |
DOC_PP1_RVXF_1 | 113 | 120 | PF00149 | 0.264 |
DOC_PP2B_LxvP_1 | 301 | 304 | PF13499 | 0.578 |
DOC_USP7_MATH_1 | 113 | 117 | PF00917 | 0.422 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.540 |
DOC_USP7_MATH_1 | 35 | 39 | PF00917 | 0.327 |
DOC_USP7_UBL2_3 | 107 | 111 | PF12436 | 0.416 |
DOC_USP7_UBL2_3 | 139 | 143 | PF12436 | 0.549 |
DOC_USP7_UBL2_3 | 156 | 160 | PF12436 | 0.436 |
DOC_USP7_UBL2_3 | 234 | 238 | PF12436 | 0.416 |
LIG_Actin_WH2_2 | 96 | 113 | PF00022 | 0.345 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.280 |
LIG_BRCT_BRCA1_1 | 223 | 227 | PF00533 | 0.509 |
LIG_BRCT_BRCA1_1 | 254 | 258 | PF00533 | 0.635 |
LIG_CaM_IQ_9 | 179 | 194 | PF13499 | 0.348 |
LIG_EH_1 | 255 | 259 | PF12763 | 0.506 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.468 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.498 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.416 |
LIG_FHA_2 | 215 | 221 | PF00498 | 0.638 |
LIG_FHA_2 | 258 | 264 | PF00498 | 0.639 |
LIG_FHA_2 | 311 | 317 | PF00498 | 0.568 |
LIG_FHA_2 | 46 | 52 | PF00498 | 0.389 |
LIG_LIR_Gen_1 | 116 | 127 | PF02991 | 0.434 |
LIG_LIR_Gen_1 | 48 | 57 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 126 | 130 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 48 | 53 | PF02991 | 0.349 |
LIG_SH2_CRK | 127 | 131 | PF00017 | 0.404 |
LIG_SH2_CRK | 43 | 47 | PF00017 | 0.407 |
LIG_SH2_CRK | 57 | 61 | PF00017 | 0.367 |
LIG_SH2_GRB2like | 318 | 321 | PF00017 | 0.553 |
LIG_SH2_GRB2like | 43 | 46 | PF00017 | 0.332 |
LIG_SH2_STAP1 | 318 | 322 | PF00017 | 0.522 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.409 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.443 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.403 |
LIG_SUMO_SIM_anti_2 | 99 | 104 | PF11976 | 0.342 |
LIG_SUMO_SIM_par_1 | 98 | 104 | PF11976 | 0.340 |
LIG_WRC_WIRS_1 | 88 | 93 | PF05994 | 0.416 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.597 |
MOD_CK2_1 | 310 | 316 | PF00069 | 0.647 |
MOD_GlcNHglycan | 291 | 294 | PF01048 | 0.722 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.467 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.538 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.419 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.568 |
MOD_GSK3_1 | 283 | 290 | PF00069 | 0.550 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.443 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.450 |
MOD_N-GLC_1 | 266 | 271 | PF02516 | 0.661 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.538 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.498 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.411 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.402 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.452 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.334 |
MOD_NEK2_2 | 113 | 118 | PF00069 | 0.342 |
MOD_PKA_1 | 283 | 289 | PF00069 | 0.564 |
MOD_Plk_1 | 137 | 143 | PF00069 | 0.463 |
MOD_Plk_1 | 208 | 214 | PF00069 | 0.391 |
MOD_Plk_1 | 310 | 316 | PF00069 | 0.594 |
MOD_Plk_2-3 | 310 | 316 | PF00069 | 0.568 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.419 |
MOD_Plk_4 | 283 | 289 | PF00069 | 0.536 |
MOD_SUMO_rev_2 | 104 | 113 | PF00179 | 0.479 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.454 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.470 |
TRG_NLS_MonoExtC_3 | 142 | 147 | PF00514 | 0.651 |
TRG_Pf-PMV_PEXEL_1 | 18 | 23 | PF00026 | 0.353 |
TRG_Pf-PMV_PEXEL_1 | 80 | 84 | PF00026 | 0.429 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PG41 | Leptomonas seymouri | 57% | 100% |
A0A1X0NY72 | Trypanosomatidae | 25% | 92% |
A0A3Q8IKU7 | Leishmania donovani | 26% | 100% |
A0A3S5H792 | Leishmania donovani | 24% | 100% |
A0A3S5H7I1 | Leishmania donovani | 100% | 100% |
A4HBK0 | Leishmania braziliensis | 21% | 100% |
A4HFU7 | Leishmania braziliensis | 74% | 100% |
A4HZL5 | Leishmania infantum | 24% | 100% |
A4HZL6 | Leishmania infantum | 27% | 100% |
E9ADF0 | Leishmania major | 93% | 100% |
E9AUW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AUW9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9AZ74 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QCL3 | Leishmania major | 22% | 100% |
Q4QCL4 | Leishmania major | 27% | 100% |